Andina Capital Management »

Halozyme Therapeutics shares owned by Andina Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Andina Capital Management from 13F filings

Historical chart of Andina Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Andina Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Andina Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $442k 6.8k 64.63

More positions owned by Andina Capital Management

Ishares Tr Core Us Aggbd Et (AGG)
Fs Kkr Capital Corp (FSK)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Innovator Etfs Trust Us Equity Accele (XDSQ)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Wisdomtree Tr Floatng Rat Trea (USFR)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Ea Series Trust Marketdesk Focus (FDIV)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Innovator Etfs Trust Laderd Alctn Pwr (BUFF)
Spdr Series Trust State Street Spd (SPTL)
Ishares Tr Rusel 2500 Etf (SMMD)

View all positions for Andina Capital Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co

View all funds holding Halozyme Therapeutics